BioPharm Weekly News Roundup—Week of Nov. 24, 2025

Welcome to the BioPharm International® weekly news roundup for the week of Nov. 24, 2025. In this video feature, the editors highlight each week’s industry news in an easy-to-consume, fun format. New roundups will drop every Friday, so be sure to come back each week. And be sure to check the links below for more in-depth coverage of each story.

Samsung Life Science Fund is investing in Phrontline Biopharma’s bispecific, dual-payload ADCs to enhance solid tumor treatment durability and targeted delivery.

FDA Commissioner’s National Priority Voucher rapid review aims to foster advanced US biomanufacturing on-shoring to secure supply chain resilience but risks resource impact.

AstraZeneca’s $2 billion Maryland investment will expand its biologics production capacity in the United States, on-shoring rare disease manufacturing and strengthening the domestic supply chain.